Literature DB >> 28333328

The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study.

Laura Cantoro1, Antonio Di Sabatino2, Claudio Papi3, Giovanna Margagnoni3, Sandro Ardizzone4, Paolo Giuffrida2, Diana Giannarelli5, Alessandro Massari4, Rita Monterubbianesi1, Marco Vincenzo Lenti2, Gino Roberto Corazza2, Anna Kohn1.   

Abstract

BACKGROUND AND AIMS: Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD.
METHODS: In total, 3392 IBD patients recorded in the registry of four IBD Italian centres were divided according to the year of diagnosis into a historical cohort [HC: 1955-84] and modern cohort [MC: 1985-2014]. DD, i.e. time lapse between onset of symptoms indicative of IBD and definitive diagnosis, was divided into four sub-periods [0-6, 7-12, 13-24, >24 months], which were correlated with age and disease location/behaviour at diagnosis.
RESULTS: Median DD in IBD was 3.0 months, it was significantly [P < 0.0001] higher in Crohn's disease [CD] [7.1 months] than in ulcerative colitis [UC] [2.0 months], and did not differ either between the HC and the MC or over the last three decades. However, the proportion of patients with a DD>24 months was significantly [P < 0.0001] higher in the HC [26.0%] than in the MC [18.2%], and the same trend was evident over the last three decades [1985-94: 19.9%; 1995-2004: 16.4%; 2005-14: 13.9%; P = 0.04]. At logistic regression analysis, age at diagnosis >40 years (CD: odds ratio 1.73, 95% confidence interval [CI] 1.31-2.28, P < 0.0001; UC: 1.41, 95% CI 1.02-1.96, P = 0.04) and complicated disease at CD diagnosis [1.39, 95% CI 1.06-1.82, P = 0.02] were independently associated with a DD>24 months.
CONCLUSIONS: DD duration has not changed over the last 60 years in Italy, but the number of IBD patients with a longer DD significantly decreased. Older age at diagnosis and a complicated disease at CD diagnosis are risk factors for longer DD.
Copyright © 2017 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Age at diagnosis; Crohn’s disease; disease behaviour; misdiagnosis; ulcerative colitis

Mesh:

Year:  2017        PMID: 28333328     DOI: 10.1093/ecco-jcc/jjx041

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  19 in total

1.  Diagnostic delay in patients with inflammatory bowel disease in Austria.

Authors:  Gottfried Novacek; Hans Peter Gröchenig; Thomas Haas; Heimo Wenzl; Pius Steiner; Robert Koch; Thomas Feichtenschlager; Gerald Eckhardt; Andreas Mayer; Andreas Kirchgatterer; Othmar Ludwiczek; Reingard Platzer; Pavol Papay; Johanna Gartner; Harry Fuchssteiner; Wolfgang Miehsler; Paul-Gerhard Peters; Gerhard Reicht; Harald Vogelsang; Clemens Dejaco; Thomas Waldhör
Journal:  Wien Klin Wochenschr       Date:  2019-02-04       Impact factor: 1.704

2.  Time between suspected and confirmed diagnoses of Crohn's disease and ulcerative colitis in patients followed in gastroenterological practices in Germany.

Authors:  Karel Kostev; Marcel Konrad; Louis Jacob
Journal:  Int J Colorectal Dis       Date:  2018-05-02       Impact factor: 2.571

3.  Infant milk-feeding practices and diagnosed celiac disease and inflammatory bowel disease in offspring: a systematic review.

Authors:  Darcy Güngör; Perrine Nadaud; Carol Dreibelbis; Concetta C LaPergola; Yat Ping Wong; Nancy Terry; Steve A Abrams; Leila Beker; Tova Jacobovits; Kirsi M Järvinen; Laurie A Nommsen-Rivers; Kimberly O O'Brien; Emily Oken; Rafael Pérez-Escamilla; Ekhard E Ziegler; Joanne M Spahn
Journal:  Am J Clin Nutr       Date:  2019-03-01       Impact factor: 7.045

4.  Incidence and prevalence of inflammatory bowel disease in Devon, UK.

Authors:  Ben Hamilton; Harry Green; Neel Heerasing; Peter Hendy; Lucy Moore; Neil Chanchlani; Gareth Walker; Claire Bewshea; Nicholas A Kennedy; Tariq Ahmad; James Goodhand
Journal:  Frontline Gastroenterol       Date:  2020-06-24

5.  Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients.

Authors:  Jesús K Yamamoto-Furusho; Norma N Parra-Holguín
Journal:  Inflamm Intest Dis       Date:  2021-12-06

6.  Early-onset versus late-onset Crohn's disease: An Italian cohort study.

Authors:  Laura Cantoro; Marco Vincenzo Lenti; Rita Monterubbianesi; Michele Cicala; Diana Giannarelli; Claudio Papi; Anna Kohn; Antonio Di Sabatino
Journal:  United European Gastroenterol J       Date:  2019-06-19       Impact factor: 4.623

7.  The Association of Introducing a Faecal Calprotectin Testing Pathway for Suspected Inflammatory Bowel Disease in Primary Care and Time to Diagnosis or Treatment.

Authors:  Amy Hicks; P John Hamlin; Christian P Selinger
Journal:  Inflamm Intest Dis       Date:  2020-09-09

8.  Association of diagnostic delay with medical cost for patients with Crohn's disease: A Japanese claims-based cohort study.

Authors:  Eisuke Takeyama; Hiroo Wada; Setsuko Sato; Kiyohide Tomooka; Ai Ikeda; Takeshi Tanigawa
Journal:  JGH Open       Date:  2021-03-24

9.  Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Authors:  Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

10.  Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.

Authors:  María Chaparro; Ana Garre; Andrea Núñez Ortiz; María Teresa Diz-Lois Palomares; Cristina Rodríguez; Sabino Riestra; Milagros Vela; José Manuel Benítez; Estela Fernández Salgado; Eugenia Sánchez Rodríguez; Vicent Hernández; Rocío Ferreiro-Iglesias; Ángel Ponferrada Díaz; Jesús Barrio; José María Huguet; Beatriz Sicilia; María Dolores Martín-Arranz; Xavier Calvet; Daniel Ginard; Inmaculada Alonso-Abreu; Luis Fernández-Salazar; Pilar Varela Trastoy; Montserrat Rivero; Isabel Vera-Mendoza; Pablo Vega; Pablo Navarro; Mónica Sierra; José Luis Cabriada; Mariam Aguas; Raquel Vicente; Mercè Navarro-Llavat; Ana Echarri; Fernando Gomollón; Elena Guerra Del Río; Concepción Piñero; María José Casanova; Katerina Spicakova; Jone Ortiz de Zarate; Emilio Torrella Cortés; Ana Gutiérrez; Horacio Alonso-Galán; Álvaro Hernández-Martínez; José Miguel Marrero; Rufo Lorente Poyatos; Margalida Calafat; Lidia Martí Romero; Pilar Robledo; Orencio Bosch; Nuria Jiménez; María Esteve Comas; José María Duque; Ana María Fuentes Coronel; Manuela Josefa Sampedro; Eva Sesé Abizanda; Belén Herreros Martínez; Liliana Pozzati; Hipólito Fernández Rosáenz; Belén Crespo Suarez; Pilar López Serrano; Alfredo J Lucendo; Margarita Muñoz Vicente; Fernando Bermejo; José Joaquín Ramírez Palanca; Margarita Menacho; Amalia Carmona; Raquel Camargo; Sandra Torra Alsina; Nuria Maroto; Juan Nerín de la Puerta; Elena Castro; Ignacio Marín-Jiménez; Belén Botella; Amparo Sapiña; Noelia Cruz; José Luis F Forcelledo; Abdel Bouhmidi; Carlos Castaño-Milla; Verónica Opio; Isabel Nicolás; Marcos Kutz; Alfredo Abraldes Bechiarelli; Jordi Gordillo; Yolanda Ber; Yolanda Torres Domínguez; María Teresa Novella Durán; Silvia Rodríguez Mondéjar; Francisco J Martínez-Cerezo; Lilyan Kolle; Miriam Sabat; Cesar Ledezma; Eduardo Iyo; Óscar Roncero; Rebeca Irisarri; Laia Lluis; Isabel Blázquez Gómez; Eva María Zapata; María José Alcalá; Cristina Martínez Pascual; María Montealegre; Laura Mata; Ana Monrobel; Alejandro Hernández Camba; Luis Hernández; María Tejada; Alberto Mir; María Luisa Galve; Marta Soler; Daniel Hervías; José Antonio Gómez-Valero; Manuel Barreiro-de Acosta; Fernando Rodríguez-Artalejo; Esther García-Esquinas; Javier P Gisbert
Journal:  J Clin Med       Date:  2021-06-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.